We are live on ! Find out more
ONSIW

Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW

Delisted

ONSIW was delisted on the 3rd of December, 2018.

Back to rankings

11 hedge funds and large institutions have $1.76M invested in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

85% more capital invested

Capital invested by funds: $954K → $1.76M (+$811K)

15% less funds holding

Funds holding: 13 → 11 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$216K
2
PA
Perceptive Advisors
New York
+$88.2K
3
UBS Group
UBS Group
Switzerland
+$1.49K
4
Morgan Stanley
Morgan Stanley
New York
+$1.42K

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$14K
2
Millennium Management
Millennium Management
New York
-$637
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$905K +$216K +475,866 +112%
PA
2
Perceptive Advisors
New York
$313K +$88.2K +193,882 +42%
CAM
3
Cormorant Asset Management
Massachusetts
$199K – – –
ACA
4
Avoro Capital Advisors
New York
$112K – – –
Marshall Wace
5
Marshall Wace
United Kingdom
$60K – – –
PC
6
PointState Capital
New York
$48K – – –
ACP
7
Acuta Capital Partners
California
$47K – – –
JG
8
Jefferies Group
New York
$42K – – –
Millennium Management
9
Millennium Management
New York
$21K -$637 -1,400 -3%
MIM
10
Monashee Investment Management
Massachusetts
$12K – – –
Morgan Stanley
11
Morgan Stanley
New York
$4K +$1.42K +3,120 +54%
UBS Group
12
UBS Group
Switzerland
$2K +$1.49K +3,279 +437%
Hudson Bay Capital Management
13
Hudson Bay Capital Management
Connecticut
– -$14K -31,250 Closed

ONSIW Hedge Fund Activity: Q3 2016 in Review

11 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) for Q3 2016, worth a combined $1.76M — up 85% from $954K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ONSIW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 4 added.

The largest buyer was Sabby Management, adding an estimated $216K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $14K sold.

  • 11 institutional investors held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) as of Q3 2016, down from 13 in Q2 2016.
  • Funds reported $1.76M of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 stock for Q3 2016, up 85% quarter-over-quarter.
  • 0 funds opened new Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 positions in Q3 2016 and 2 closed out, a net change of -2 holders.
  • The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 buyer in Q3 2016 was Sabby Management, an estimated $216K added.
  • The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 seller in Q3 2016 was Hudson Bay Capital Management, an estimated $14K sold.

Based on aggregated 13F filings for Q3 2016.